Brambles Flags Further Earnings Rise After Lifting Annual Profit
By Stuart Condie
SYDNEY--Brambles lifted its final dividend and flagged a further rise in underlying profit for the year ahead after price rises drove an increase in annual earnings.
The Australia-listed pallet supplier on Wednesday reported an underlying profit for the 12 months through June of US$1.07 billion, up 19% once currency moves are stripped out. That compared with April's improved guidance of a 17%-19% increase and US$930.0 million a year earlier.
Sales revenue from continuing operations rose by 14% to US$6.08 billion, also on a constant-currency basis. The company had guided for a 14%-15% rise.
Brambles reported a net profit of US$703.3 billion on a statutory basis, up 24% on-year at constant FX rates. The average analyst forecast had been for a statutory net profit of US$660 million off revenue of US$6.17 billion, according to data compiled by FactSet.
Directors declared a final dividend of 14 U.S. cents, compared with 12.0 U.S. cents a year ago.
Brambles expects underlying profit to rise by 9-12% in its 2024 fiscal year, which began on July 1. It expects 6-8% higher revenue and positive free cash flow before dividends of between US$450 million and US$550 million.
Write to Stuart Condie at stuart.condie@wsj.com
(END) Dow Jones Newswires
August 29, 2023 18:45 ET (22:45 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
How the Tokyo Stock Exchange Is Pushing for Better Capital Allocation
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom
-
Albemarle Earnings: We Expect Improved Results In the Rest of Year Following Cyclically Low Profits
-
Novo Nordisk Earnings: Raised Fair Value Estimate Still a Contrast to Market Overenthusiasm
-
After Earnings, Is Verizon Stock a Buy, a Sell, or Fairly Valued?
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting